SMN Blood Levels in a Porcine Model of Spinal Muscular Atrophy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neuromuscular Diseases

• Publication date

  2017-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JND-170209PMID 28269795PMCID PMC5531281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

  2016cited by this paper
• SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials

  2016cited by this paper
• Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.

  2016cited by this paper
• Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.

  2015cited by this paper
• Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults

  2015cited by this paper
• A large animal model of spinal muscular atrophy and correction of phenotype

  2015cited by this paper
• Spinal muscular atrophy: Development and implementation of potential treatments

  2013cited by this paper
• Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study

  2012cited by this paper
• Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders

  2011cited by this paper
• Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

  2011cited by this paper
• Spinal muscular atrophy: a timely review.

  2011cited by this paper
• Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

  2011influential reference
• Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs

  2011cited by this paper
• Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

  2010cited by this paper
• A positive modifier of spinal muscular atrophy in the SMN2 gene.

  2009cited by this paper
• SMN mRNA and protein levels in peripheral blood

  2006cited by this paper
• In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate

  2006cited by this paper
• Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2

  2002cited by this paper
• A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.

  1999cited by this paper
• A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

  1999cited by this paper
• Correlation between severity and SMN protein level in spinal muscular atrophy

  1997cited by this paper
• The survival motor neuron protein in spinal muscular atrophy.

  1997cited by this paper
• Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

  1997cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• The Gene Frequency of Acute Werdnig-Hoffmann Disease (SMA Type 1). A Total Population Survey in North-East England

  1973cited by this paper

• Theme 4 In Vivo Experimental Models

  2025cites this paper
• Application of Biomarkers in Spinal Muscular Atrophy

  2025cites this paper
• Insights into spinal muscular atrophy from molecular biomarkers

  2024cites this paper
• Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen

  2023cites this paper
• Biomarkers in 5q-associated spinal muscular atrophy—a narrative review

  2023cites this paper
• Recognising the potential of large animals for modelling neuromuscular junction physiology and disease

  2022cites this paper
• Update on Biomarkers in Spinal Muscular Atrophy

  2021cites this paper
• Perinatal fluoxetine exposure results in social deficits and reduced monoamine oxidase gene expression in mice.

  2020cites this paper
• Astrocytes in Motor Neuron Diseases.

  2019cites this paper
• Protocol for the long‐term culture of human primary keratinocytes from the normal colorectal mucosa

  2019cites this paper
• Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice

  2018cites this paper
• Natural history of infantile‐onset spinal muscular atrophy

  2017cites this paper